Thromb Haemost 2016; 116(01): 198-200
DOI: 10.1160/TH15-12-0999
Letters to the Editor
Schattauer GmbH

NOX 5 is expressed in platelets from patients with chronic granulomatous disease

Simona Bartimoccia*
1   Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy
,
Roberto Carnevale*
1   Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy
2   Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
,
Valerio Sanguigni
3   Department of Internal Medicine, University of Rome “Tor Vergata”, Rome, Italy
,
Elena De Falco
2   Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
,
Giacomo Frati
2   Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
4   Department of AngioCardioNeurology, IRCCS NeuroMed, Pozzilli, Italy
,
Lorenzo Loffredo
1   Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy
,
Alessandro Plebani
5   Department of Pediatrics and Institute of Molecular Medicine “A. Nocivelli”, University of Brescia, Brescia, Italy
,
Annarosa Soresina
5   Department of Pediatrics and Institute of Molecular Medicine “A. Nocivelli”, University of Brescia, Brescia, Italy
,
Pasquale Pignatelli**
1   Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy
,
Francesco Violi**
1   Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy
› Author Affiliations
Further Information

Publication History

Received: 29 December 2015

Accepted after minor revision: 02 March 2016

Publication Date:
27 November 2017 (online)

 

* Drs Bartimoccia and Carnevale equally contributed to this work.


** Drs Pignatelli and Violi are joint senior authors.


 
  • References

  • 1 Martire B, Rondelli R, Soresina A. et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol 2008; 126: 155-164.
  • 2 Segal BH, Leto TL, Gallin JI. et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 2000; 79: 170-200.
  • 3 Pignatelli P, Carnevale R, Di Santo S. et al. Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arterioscler Thromb Vasc Biol 2011; 31: 423-434.
  • 4 Violi F, Pignatelli P. Platelet NOX, a novel target for anti-thrombotic treatment. Thromb Haemost 2014; 111: 817-823.
  • 5 Pignatelli P, Sanguigni V, Lenti L. et al. gp91phoxdependent expression of platelet CD40 ligand. Circulation 2004; 110: 1326-1329.
  • 6 Bedard K, Krause KH. The NOX family of ROSgenerating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
  • 7 Dayal S, Wilson KM, Motto DG. et al. Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation 2013; 127: 1308-1316.
  • 8 Walsh TG, Berndt MC, Carrim N. et al. The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation. Redox Biol 2014; 02: 178-186.
  • 9 Scafetta G, Tricoli E, Siciliano C. et al. Suitability of Human Tenon’s Fibroblasts as Feeder Cells for Culturing Human Limbal Epithelial Stem Cells. Stem Cell Rev 2013; 09: 847-857.
  • 10 De Falco E, Scafetta G, Napoletano C. et al. A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon’s fibroblasts. Cell Tissue Bank 2013; 14: 277-287.
  • 11 Basili S, Pignatelli P, Tanzilli G. et al. Anoxia-reoxygenation enhances platelet thromboxane A2 production via reactive oxygen species-generated NOX2: effect in patients undergoing elective percutaneous coronary intervention. Arterioscler Thromb Vasc Biol 2011; 31: 1766-1771.
  • 12 Vara D, Campanella M, Pula G. The novel NOX inhibitor 2-acetylphenothiazine impairs collagendependent thrombus formation in a GPVI-dependent manner. Br J Pharmacol 2013; 168: 212-224.
  • 13 Pandey D, Gratton JP, Rafikov R. et al. Calcium/ calmodulin-dependent kinase II mediates the phosphorylation and activation of NADPH oxidase 5. Mol Pharmacol 2011; 80: 407-415.